researchers say the vaccine could make a ‘ substantial contribution’ to controlling the disease .
drug firm glaxosmithkline has applied for a licence from the european medicines agency ( ema ) for the rts , s vaccine .
the news is significant because rts , s is the first malaria vaccine to reach advanced trials .